Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
about
Understanding the interplay between host immunity and Epstein-Barr virus in NPC patientsModulation of DNA damage and repair pathways by human tumour virusesRoles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implicationsCrystal structure of a KSHV-SOX-DNA complex: insights into the molecular mechanisms underlying DNase activity and host shutoffEpstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesisThe synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cellsTransformation of the genital epithelial tract occurs early in California sea lion developmentChromosomal variation in lymphoblastoid cell linesEpstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.Necrosis is increased in lymphoblastoid cell lines from children with autism compared with their non-autistic siblings under conditions of oxidative and nitrosative stressEBV reactivation as a target of luteolin to repress NPC tumorigenesis.Altered expression of the mismatch repair genes in DF-1 cells infected with the avian leukosis virus subgroup A.Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.Effects of parental radiation exposure on developmental instability in grasshoppers.How virus persistence can initiate the tumorigenesis process.Switching of EBV cycles between latent and lytic states.Modes of infection and oncogenesis by the Epstein-Barr virus.Regulation of Epstein-Barr virus reactivation from latency.The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.Epstein-Barr virus: more than 50 years old and still providing surprises.The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.Epstein-Barr virus infection and nasopharyngeal carcinoma.Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.Induction of DNA damages upon Marek's disease virus infection: implication in viral replication and pathogenesis.Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.Epstein-Barr virus BRLF1 induces genomic instability and progressive malignancy in nasopharyngeal carcinoma cells.Pyruvate kinase M2 phosphorylates H2AX and promotes genomic instability in human tumor cells.Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies.Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
P2860
Q26823898-CFB0F2FB-70A8-41B7-AA51-70BDD69C1836Q26825783-78016418-7B17-49A4-BDF3-0B561CA133A6Q27009016-9AB06119-4C73-4E45-992D-9DACA35A1F8BQ27667301-2E32FE61-7948-4770-BB17-F2883D6D5056Q28079510-329985BD-AA72-45F6-9DD4-40BF83E11DD2Q28483778-B62852BE-310D-4036-99F7-2109A926706FQ28601256-2184BC7C-10EB-448A-A8CB-856B04304604Q28728704-231B3A23-45F8-44AE-A73D-D086FC8E66C7Q34483687-7CD7398B-4D03-4536-B26A-E54BE3A8DDA0Q35624112-DEA72C00-5186-491F-9AA8-CF64D3C86B77Q36926262-6775281B-21B1-4188-A798-C229DC69275AQ37109915-6E083A7B-335A-49BE-822B-A2BC27798FC5Q37321792-17904D34-6DAE-4714-994F-9E38E539475AQ37566280-84456BF3-C685-4DBB-A850-65F575543730Q37659652-BD3F4C3D-F5A8-4AE7-8840-80E3CFC42A32Q38156891-4B7993D4-4688-450F-8974-7B215AF9D92AQ38171455-CD7FCA24-C7B9-4A16-85A8-C4798AB03921Q38191876-043CCCB6-57F9-4EA5-8ED9-52AD1CF48341Q38208532-5AD39E86-32C8-40AB-B0EF-B5DF0A24DCA6Q38440804-72C956D3-AE96-41A7-BF32-A49E3DD5F79DQ38968588-54E0C390-0572-457F-87FB-55F3D69384F3Q39344275-5562D534-9ED8-4277-BEBA-1E757CAD6C1BQ40046633-36AF32A8-A881-40F4-AB79-D002969D428EQ40468163-3ADCC63D-5B49-469D-8936-19497AF2E8AAQ41924225-D6ED9491-BD37-4D93-B98D-CE76C3E1297FQ42717841-C5FFBC39-EAE7-4E72-B9CC-23D8E5F44C70Q43206312-7490E4EB-FD0C-4010-A23F-E24A6ACF1296Q47239224-55BC8FD9-F665-4CC5-BDC2-5BACEB4DE8AFQ49787173-5899FEF8-DF4A-4B95-8155-1B1978E58A49Q54232271-E386A4B3-919D-4867-8C90-BC47018EEBDEQ54245037-95F74F0C-DDF3-41B5-BFF2-051E297CC926Q55518172-9C2AF77C-8AAD-41F6-A1FF-0E9532FEF5E0Q58711257-52211455-3A66-45AB-A130-E34ED9164A5F
P2860
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
@ast
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
@en
type
label
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
@ast
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
@en
prefLabel
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
@ast
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
@en
P2093
P2860
P356
P1476
Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.
@en
P2093
Chia-Huei Lee
Chih-Yeu Fang
Chung-Chun Wu
Hsin-Wei Liao
Hsin-Ying Chuang
Jen-Yang Chen
Kuan-Lin Kuo
Ming-Tsan Liu
Pei-Wen Wang
Sheng-Ping Chou
P2860
P304
P356
10.1093/NAR/GKP1169
P407
P50
P577
2009-12-23T00:00:00Z